HYDE-SMITH, COLLEAGUES DEMAND ANSWERS ON FDA FAILURES BEHIND BABY FORMULA SHORTAGE
HYDE-SMITH, COLLEAGUES DEMAND ANSWERS ON FDA FAILURES BEHIND BABY FORMULA SHORTAGE
Senators Maintain Biden Administration, FDA should have Anticipated Crisis, Citing Declining Supplies Starting in mid-2021
WASHINGTON, D.C. – U.S. Senator Cindy Hyde-Smith (R-Miss.) and 21 colleagues today demanded the Food and Drug Administration (FDA) explain why the Biden administration didn’t act sooner to ensure the availability of infant formula, supplies of which began to decline in mid-2021.
In a letter...